Trial Profile
A Pilot Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure
Status:
Not yet recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 09 May 2018
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 17 May 2016 New trial record